Biocon, Iatrica in immunoconjugates deal

Biocon (NSE:BIOCON; BSE:BIOCON) and Iatrica (Baltimore, Md.) partnered to co-develop antibody-based immunoconjugates to treat cancer and infectious diseases. Iatrica will use its immunoconjugate techn...